{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hereditary-breast-carcinoma","columns":[{"gene":"","key":"population-b2f6341ab1e616f1ccac","label":"Breast cancer","mondoId":"MONDO:0016419","onsetQualifier":null,"originColumnKey":"MONDO:0016419/OMIM:114480","originalViews":[{"key":"MONDO:0016419/OMIM:114480","label":"Breast cancer","scopeLabel":"OMIM:114480","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0c4154cef43e3300c2b8f227439d00540f64399d75767055f0e7861a73373a69"],"recordQualifiers":{},"scopeLabel":"OMIM:114480","sourceIds":["OMIM:114480"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-b2f6341ab1e616f1ccac"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003002"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":1,"sourceGroups":{"omim":1}},"features":[{"hpoId":"HP:0003002","label":"Breast carcinoma","primary":true}],"ledeHtml":"A rare genetic gynecological tumor characterized by early onset breast cancer in association with a germline mutation. Tumors arising in carriers of BRCA1 and BRCA2 mutations differ morphologically and genetically from each other, as well as from sporadic breast cancers. Most BRCA1 -associated tumors are invasive ductal adenocarcinomas of no special type, typically of higher grade than sporadic tumors, and more often negative for hormone receptors. In addition, more cases with features of typical or atypical medullary carcinoma are seen in these patients. Likewise, BRCA2 -associated tumors tend to be of higher grade than sporadic ones, although their phenotype is similar. They show a low frequency of HER-2 expression.","mondoId":"MONDO:0016419","node":{"canonicalSlug":"hereditary-breast-carcinoma","comparisons":[{"documentSha256":"b40c2e32d2a22174133001176f5147b450eaa69a66aa839f24f100c606c730fc","key":"legacy-hereditary-breast-carcinoma","kind":"legacy","label":"hereditary breast carcinoma","memberIds":["MONDO:0016419"],"mondoId":"MONDO:0016419","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hereditary-breast-carcinoma.b40c2e32d2a22174133001176f5147b450eaa69a66aa839f24f100c606c730fc.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Familial cancer of breast","originalSourceId":"ORPHA:227535","paragraphs":["A rare genetic gynecological tumor characterized by early onset breast cancer in association with a germline mutation. Tumors arising in carriers of BRCA1 and BRCA2 mutations differ morphologically and genetically from each other, as well as from sporadic breast cancers. Most BRCA1 -associated tumors are invasive ductal adenocarcinomas of no special type, typically of higher grade than sporadic tumors, and more often negative for hormone receptors. In addition, more cases with features of typical or atypical medullary carcinoma are seen in these patients. Likewise, BRCA2 -associated tumors tend to be of higher grade than sporadic ones, although their phenotype is similar. They show a low frequency of HER-2 expression."],"rawAttribution":"MONDO:0016419","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T15:49:57Z","upstream":"ORPHA:227535","url":"https://rarediseases.info.nih.gov/diseases/17142"},"ownColumnKeys":["population-b2f6341ab1e616f1ccac"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null},{"kind":"parent","label":"breast carcinoma","mondoId":"MONDO:0004989","slug":null},{"kind":"child","label":"CTNNA1-related diffuse gastric and lobular breast cancer syndrome","mondoId":"MONDO:0100256","slug":"ctnna1-related-diffuse-gastric-and-lobular-breast-cancer"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"multiple-identity-targets","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/breast-cancer"}],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"0c4154cef43e3300c2b8f227439d00540f64399d75767055f0e7861a73373a69","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"OMIM:114480","disease_name":"Breast cancer","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003002","is_excluded":false,"label":"Breast carcinoma","onset_id":null,"reference":"OMIM:114480","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17142\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016419\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:227535</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare genetic gynecological tumor characterized by early onset breast cancer in association with a germline mutation. Tumors arising in carriers of BRCA1 and BRCA2 mutations differ morphologically and genetically from each other, as well as from sporadic breast cancers. Most BRCA1 -associated tumors are invasive ductal adenocarcinomas of no special type, typically of higher grade than sporadic tumors, and more often negative for hormone receptors. In addition, more cases with features of typical or atypical medullary carcinoma are seen in these patients. Likewise, BRCA2 -associated tumors tend to be of higher grade than sporadic ones, although their phenotype is similar. They show a low frequency of HER-2 expression.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17142\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"hereditary-breast-carcinoma","sourceDocuments":[{"name":"GARD: Familial cancer of breast","reviewed":null,"source_release":"2026-10-21T15:49:57Z","url":"https://rarediseases.info.nih.gov/diseases/17142"},{"name":"MONDO: hereditary breast carcinoma","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0016419"}],"sourceNote":"","synonyms":["breast cancer susceptibility, autosomal dominant, somatic mutation","breast cancer, early-onset, susceptibility to, autosomal dominant, somatic mutation","breast cancer, invasive ductal, autosomal dominant, somatic mutation","breast cancer, lobular, somatic","breast cancer, male, susceptibility to, autosomal dominant, somatic mutation","breast cancer, protection against, autosomal dominant, somatic mutation","breast cancer, somatic","breast cancer, susceptibility to, autosomal dominant, somatic mutation","familial breast cancer","familial breast carcinoma","familial cancer of breast","familial cancer of the breast","hereditary breast cancer","hereditary breast carcinoma"],"takeawayHtml":"","title":"hereditary breast carcinoma"},"schemaVersion":1}
